At 10 days post ETV2 overexpression, multicolor immunostaining also showed that ETV2 overexpression in primary GBM tumor cells induced significant expression of endothelial marker genes (kdrl, VE-Cad, and CD31). The gene discussed is PECAM1; the disease is glioblastoma.